NEW YORK/TEL AVIV (Reuters) - Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin has promised investors it will be a very different company going forward. Next week he has to prove it. Levin's ability to paint a bright future for the world's biggest maker of generic drugs at a meeting with investors and analysts on December 11 in New York became a bit more difficult last week, when Teva issued a 2013 earnings forecast that fell short of Wall Street estimates. ...
Source: news.yahoo.com
No comments:
Post a Comment